About CalciMedica CalciMedica is a clinical-stage biopharmaceutical company focused on developing novel CRAC channel inhibition therapies for inflammatory and immunologic diseases. CalciMedica's ...

AstraZeneca’s IMFINZI® (durvalumab) in combination with gemcitabine and cisplatin as neoadjuvant treatment, followed by IMFINZI as adjuvant monotherapy after radical cystectomy (surgery to remove the ...

AstraZeneca's IMFINZI® (durvalumab) in combination with gemcitabine and cisplatin as neoadjuvant treatment, followed by IMFINZI as adjuvant monotherapy after radical cystectomy (surgery to remove the ...

It is sometime in the prehistoric era. The Earth is a wilderness. There are no modern conveniences. The world is a wild and primitive place. Animals large and small, harmless and predatory, roam ...

ASHBURN, VA, April 2, 2025 (EZ Newswire) -- Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (“Quoin” or the “Company”), a late-stage specialty pharmaceutical company focused on rare and orphan ...

WASHINGTON, April 1 (Reuters) - Democrats on the U.S. House of Representatives oversight committee opened an investigation on Tuesday into health secretary Robert F. Kennedy Jr.'s handling of the ...

France’s Council of State rejects contention by campaigners that racial profiling by police is systemic Local grassroots organizations and international rights groups had hoped that a favorable ...

A 2015 systemic review recommends drug therapy to lower your systolic blood pressure (top number) if it’s above 130 mm Hg. If you’re living with diabetes, treating high blood pressure reduces ...

NF-YA responds to TGFβ1 and IL-6 signals to regulate Klhl25 transcription, thereby controlling ACLY ubiquitination and the transition of fatty acids metabolism, which constitutes a determinant ...

Guillain-Barré syndrome (GBS) is an acute inflammatory neuropathy that can lead to severe weakness of the limbs, face, and respiratory muscles. Its pathophysiology involves autoantibodies that ...